AUS
NZ
UK
CA
USA
IND
Highlights
- Quantbot Technologies LP reduced its stake in Chemed by 77.6% in Q3.
- Institutional investors own 95.85% of Chemed's shares.
- Chemed’s stock recently traded at $572.39, reflecting market performance.
Chemed Corp , a prominent name in the healthcare sector, operates through its VITAS hospice services and Roto-Rooter plumbing division. As part of the NYSE Healthcare Stocks, Chemed's performance has attracted significant institutional interest. The company continues to demonstrate stability with consistent revenue growth and a strong market presence, solidifying its role in the healthcare industry.
Institutional Activity in Chemed Corp (NYSE:CHE)
Chemed Corp , has recently seen a shift in its institutional holdings, with several hedge funds adjusting their positions in the company. Quantbot Technologies LP significantly reduced its stake by 77.6% during the third quarter, now owning just 1,581 shares after selling 5,476 shares. Despite this, the company continues to maintain strong backing from institutional investors, with 95.85% of its stock held by hedge funds and other large firms. Kayne Anderson Rudnick Investment Management LLC, for instance, increased its holdings by 2.6% in the second quarter, now owning more than 580,000 shares of Chemed.
Other firms like FMR LLC have also been active, growing their position by 23.8% in the third quarter. These movements indicate ongoing interest from large financial institutions despite individual changes in stock positions. Institutional ownership plays a key role in stabilizing stock performance, particularly for established companies like Chemed, which operates in the healthcare sector with a diversified business model across hospice care and plumbing services.
Chemed's Financial Performance
Chemed's financial results for the third quarter revealed a slight miss in earnings per share (EPS), reporting $5.64, slightly below analysts' estimates of $5.76. However, the company experienced revenue growth, with quarterly revenue reaching $606.18 million, a 7.4% increase compared to the same quarter last year. This continued growth highlights Chemed’s strong position in its market segments, particularly in its VITAS hospice services.
Despite the slight miss in EPS, Chemed’s return on equity of 27.86% demonstrates its ability to generate significant profits relative to shareholder equity. The company also boasts a solid net margin of 12.69%, reflecting efficient operations and a profitable business model.
Dividend Payments and Future Outlook
Chemed has also maintained its commitment to rewarding shareholders with a quarterly dividend. The upcoming dividend of $0.50 per share is set to be paid on December 6th. This brings the total annual dividend to $2.00, offering a yield of 0.35%. Chemed's payout ratio of 10.11% reflects its conservative approach to distributing profits, ensuring a balance between rewarding shareholders and reinvesting in the business for future growth.
Chemed Corp , remains a significant entity in the healthcare sector, with strong institutional backing and consistent financial performance. While there were slight deviations from earnings expectations, the company's overall growth and stability in both the hospice and plumbing segments reflect its ongoing success in a competitive market. With a healthy dividend payout and an optimistic outlook, Chemed is poised to maintain its position as a prominent player in the healthcare industry.
